Saturday, February 8, 2014 6:30 a.m. Registration Opens 7:00-8:30 a.m. Exhibitor Experience with Continental Breakfast Sponsored by Blesstia Pharmaceutical. Caribbean Salons III-IV GENERAL SESSION 8:30-10:30 a.m. New Drug Update Caribbean Salons V-VIII 0201-9999-14-020-L01-P/T Pharmacists will be able to identify the advantages and disadvantages of the new drugs compared to older medications to which they are most similar in activity. At the conclusion of this educational session, the pharmacist and technician attendee will be able to: • Identify the indications and routes of administration of the new therapeutic agents. • Identify the most important pharmacokinetic properties, adverse events, and precautions of the new drugs. • Compare the new drugs to the older therapeutic agents to which they are most similar in activity. • Discuss information regarding the new drugs that should be communicated to patients. Presented by: Daniel A. Hussar, PhD, Philadelphia College of Pharmacy Program Type: Knowledge-Based What’s Going on Legislatively & Judicially? A Pharmacy Law Update Caribbean Salons V-VIII 0201-9999-14-021-L03-P/T Most pharmacists rely on their professional associations or their Board of Pharmacy to keep them informed and up-to-date about changes in practice acts at the federal and state levels. But did you know that the judicial branch – the court system – also affects pharmacy law? Over the past year, there have been some interesting legal challenges pertaining to pharmacy and pharmaceuticals which directly affect your daily practice. This session will provide an easy-to-understand overview of the key court decisions as well as some of the upcoming cases you need to know about in order to protect your practice and your business. At the conclusion of this educational session, the pharmacist and technician attendee will be able to: • Discuss FDA inspection authority in light of Medical Center Pharmacy v. Holder. • Discuss potential new legislation at the federal level. • Discuss trends among the states in regard to compounding pharmacies. Presented by: Deborah A. Pearce, JD, Deborah A. Pearce, LLC (Attorney) Program type: Knowledge-Based 10:30 a.m.-12:30 p.m. The Educational Conference has been approved for 31.5 contact hours (3.15 CEUs) and attendees may acquire up to 14 contact hours (1.4 CEUs) of continuing education credit. Attendees will be required to complete an online evaluation for each CE session they attend to verify attendance and acquire their CE. Attendees must provide their NABP e-Profile ID and birthdate (MMDD) to receive credit for any ACPE-accredited CPE session. It is the responsibility of the CPE taker to give correct information. If incorrect information is provided, the record will be rejected by the CPE Monitor and the CPE credit will not be awarded. If you complete an online evaluation for each CE session you attend at the conclusion of the conference, your CPE credits will be uploaded to the CPE Monitor System within 60 days of completion. If you do not see CPE activity displayed for a session that you attended and it has been more than 60 days since you submitted the CPE to the provider, please contact your CPE provider. All sessions carrying the ACPE program number are approved for continuing education credit. The American College of Apothecaries, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 13 This program is made possible through an unrestricted educational grant-in-aid from Humco Compounding. COMPOUNDING EducationalConference.org
2014 EduConf Meeting Syllabus
To see the actual publication please follow the link above